HomeCompareAMPE vs MCD

AMPE vs MCD: Dividend Comparison 2026

AMPE yields 1311.05% · MCD yields 2.35%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AMPE wins by $207537754.77M in total portfolio value
10 years
AMPE
AMPE
● Live price
1311.05%
Share price
$0.15
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$207537754.85M
Annual income
$180,460,634,612,456.80
Full AMPE calculator →
MCD
McDonald's Corporation
● Live price
2.35%
Share price
$308.53
Annual div
$7.26
5Y div CAGR
42.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$78.5K
Annual income
$26,227.70
Full MCD calculator →

Portfolio growth — AMPE vs MCD

📍 AMPE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAMPEMCD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AMPE + MCD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AMPE pays
MCD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AMPE
Annual income on $10K today (after 15% tax)
$111,438.87/yr
After 10yr DRIP, annual income (after tax)
$153,391,539,420,588.28/yr
MCD
Annual income on $10K today (after 15% tax)
$200.01/yr
After 10yr DRIP, annual income (after tax)
$22,293.55/yr
At 15% tax rate, AMPE beats the other by $153,391,539,398,294.75/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AMPE + MCD for your $10,000?

AMPE: 50%MCD: 50%
100% MCD50/50100% AMPE
Portfolio after 10yr
$103768877.46M
Annual income
$90,230,317,319,342.25/yr
Blended yield
86.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MCD right now

AMPE
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
-63.7
Piotroski
3/9
MCD
Analyst Ratings
37
Buy
23
Hold
1
Sell
Consensus: Buy
Price Target
$351.76
+14.0% upside vs current
Range: $320.00 — $385.00
Altman Z
4.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AMPE buys
0
MCD buys
0
No recent congressional trades found for AMPE or MCD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAMPEMCD
Forward yield1311.05%2.35%
Annual dividend / share$2.00$7.26
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%42.3%
Portfolio after 10y$207537754.85M$78.5K
Annual income after 10y$180,460,634,612,456.80$26,227.70
Total dividends collected$205538221.53M$58.5K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary
Analyst consensusBuyBuy

Year-by-year: AMPE vs MCD ($10,000, DRIP)

YearAMPE PortfolioAMPE Income/yrMCD PortfolioMCD Income/yrGap
1← crossover$141,805$131,104.56$10,815$334.85+$131.0KAMPE
2$1,889,228$1,737,497.51$11,826$491.71+$1.88MAMPE
3$23,655,368$21,633,893.61$13,123$730.06+$23.64MAMPE
4$278,471,869$253,160,624.79$14,853$1,100.07+$278.46MAMPE
5$3,083,213,738$2,785,248,838.88$17,257$1,690.61+$3083.20MAMPE
6$32,119,606,169$28,820,567,469.38$20,752$2,667.01+$32119.59MAMPE
7$314,966,468,315$280,598,489,713.88$26,103$4,354.83+$314966.44MAMPE
8$2,908,568,193,145$2,571,554,072,047.85$34,794$7,437.78+$2908568.16MAMPE
9$25,305,719,846,817$22,193,551,880,152.03$49,926$13,461.60+$25305719.80MAMPE
10$207,537,754,848,551$180,460,634,612,456.80$78,550$26,227.70+$207537754.77MAMPE

AMPE vs MCD: Complete Analysis 2026

AMPEStock

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of immunomodulatory therapies for the treatment of pain from osteoarthritis in the United States. Its product pipeline includes AP-013, an intra-articular injection, which is in phase III clinical trial for the treatment of osteoarthritis of the knee; AP-017, an intravenous ampion treatment that is in Phase II clinical trial to treat adult COVID-19 patients requiring oxygen supplementation; AP-019, an Inhaled Ampion treatment, which is in Phase II clinical trial for the treatment of Adults with Respiratory Distress Due to COVID-19; and AP-018 that is in Phase I clinical trial to treat patients with prolonged respiratory symptoms due to COVID-19. The company is headquartered in Englewood, Colorado.

Full AMPE Calculator →

MCDConsumer Discretionary

McDonald's Corporation operates and franchises McDonald's restaurants in the United States and internationally. Its restaurants offer hamburgers and cheeseburgers, chicken sandwiches and nuggets, wraps, fries, salads, oatmeal, shakes, desserts, sundaes, soft serve cones, bakery items, soft drinks, coffee, and beverages and other beverages, as well as breakfast menu, including biscuit and bagel sandwiches, breakfast burritos, hotcakes, and other sandwiches. As of December 31, 2021, the company operated 40,031 restaurants. McDonald's Corporation was founded in 1940 and is headquartered in Chicago, Illinois.

Full MCD Calculator →
📬

Get this AMPE vs MCD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AMPE vs SCHDAMPE vs JEPIAMPE vs OAMPE vs KOAMPE vs MAINAMPE vs YUMAMPE vs QSRAMPE vs SBUX

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.